Paroxysmal Kinesigenic Dyskinesia: First Molecularly Confirmed Case from Africa

Dekker, Marieke C.J.; Chengo, Rose; Kumburu, Happiness H.; Kamsteeg, Erik-Jan; Hamel, Ben C.

Background: Paroxysmal kinesigenic dyskinesia (PKD) is a movement disorder, with an excellent response to carbamazepine treatment. It has been described in various populations, but not yet in an African population.

Case report: In a patient who reported to clinic with side effects of carbamazepine, PRRT2 gene screening was performed based on a clinical history compatible with PKD. A common PRRT2 mutation was identified in this patient, hereby the first genetically confirmed PRRT2-associated PKD in Africa.

Discussion: Reporting genetic confirmation of an unusual movement disorder from an equally unusual location shows the wide geographical distribution of PRRT2-associated disease. It also illustrates recognizability of this treatable disorder where the easiest accessible diagnostic tool is neurological history and examination.

Geographic Areas


  • thumnail for 742-Article Text-17104-1-10-20200110.pdf 742-Article Text-17104-1-10-20200110.pdf application/pdf 136 KB Download File

Also Published In

Tremor and Other Hyperkinetic Movements

More About This Work

Academic Units
Center for Parkinson's Disease and Other Movement Disorders
Published Here
January 16, 2020